2012 News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
Santen Announces Financial Result for the Second Quarter ended September 30, 2012
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
Notice on the Establishment of a New Sales and Marketing Company in China
-
Press Release IR News
Eisai and Santen Enter into Option Agreement for New Ophthalmic Drugs
-
Press Release IR News
-
Press Release IR News
Santen Announces Financial Result for the First Quarter ended June 30, 2012
-
Press Release IR News
-
Press Release IR News
Notice on the Exercise Price of Stock Options (Stock Acquisition Rights)
-
Press Release IR News
-
Press Release IR News
Notice on the Allotment of Stock Options (Stock Acquisition Rights)
-
Press Release IR News
Santen Announces Financial Results for the Year ended March 31, 2012
-
Press Release IR News
Santen to Issue Rights to Subscribe for New Shares as Stock Options in favor of Directors
-
Press Release IR News
Santen to Issue Rights to Subscribe for New Shares as Stock Options in favor of Corporate Officers
-
Press Release IR News
Notice of the Nominations for the members of the Board of Directors
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
Santen Announces Financial Result for the Third Quarter ended December 31, 2011
-
Press Release IR News
-
Press Release IR News
Santen to Launch Nutritional Supplement Sante Lutax 20 + DHA